Significant association of rs13376333 in KCNN3 on chromosome 1q21 with atrial fibrillation in a Taiwanese population

Circulation Journal

Volumn 76, Issue 1, 2012, Pages 184-188

  Chang, Shu Hsuan ^a   Chang, Sheng Nan ^b   Hwang, Juey Jen ^b   Chiang, Fu Tien ^b,c   Tseng, Chuen Den ^b   Lee, Jen Kuang ^c   Lai, Ling Ping ^b,c   Lin, Jiunn Lee ^b,c   Wu, Cho Kai ^b   Tsai, Chia Ti ^b  

^a LOTUNG POH AI HOSPITAL   (Taiwan)

^b Division of Cardiology   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Atrial fibrillation; Genetics; Single nucleotide polymorphism

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 1Q; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY MONITORING; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMORPHIC LOCUS; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL CONDUCTANCE CALCIUM ACTIVATED CHANNEL SUBFAMILY N MEMBER 3 GENE; TAIWAN;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; TAIWAN;

EID: 84455180753     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0525     Document Type: Article

References (29)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982; 306: 1018-1022.
2. Benjamin EJ, Levy D, Vaziriet SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population- based cohort: The Framingham Heart Study. JAMA 1994; 271: 840-844.
3. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354.
4. JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): Digest version. Circ J 2010; 74: 2479-2500.
5. Fox CS, Parise H, D'Agostino RB, Lloyd-Jones DM, Vasan RS, Wang TJ, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004; 291: 2851-2855.
6. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448: 353-357.
7. Gudbjartsson DF, Holm H, Gretarsdottir S, Thorleifsson G, Walters GB, Thorgeirsson G, et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet 2009; 41: 876-878.
8. Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV, et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet 2009; 41: 879-881.
9. Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, Chung MK, et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 2010; 42: 240-244.
10. Viviani Anselmi C, Novelli V, Roncarati R, Malovini A, Bellazzi R, Bronzini R, et al. Association of rs2200733 at 4q25 with atrial flutter/ fibrillation diseases in an Italian population. Heart 2008; 94: 1394-1396.
11. Kaab S, Darbar D, van Noord C, Dupuis J, Pfeufer A, Newton-Cheh C, et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J 2009; 30: 813-819.
12. Shi L, Li C, Wang C, Xia Y, Wu G, Wang F, et al. Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population. Hum Genet 2009; 126: 843-849.
13. Li C, Wang F, Yang Y, Fu F, Xu C, Shi L, et al. Significant association of SNP rs2106261 in the ZFHX3 gene with atrial fibrillation in a Chinese Han GeneID population. Hum Genet 2011; 129: 239-246.
14. Lee KT, Yeh HY, Tung CP, Chu CS, Cheng KH, Tsai WC, et al. Association of RS2200733 but not RS10033464 on 4q25 with atrial fibrillation based on the recessive model in a Taiwanese population. Cardiology 2010; 116: 151-156.
15. Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD, et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 2004; 109: 1640-1646.
16. Lahri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
17. Ruo B, Capra AM, Jensvold NG, Go AS. Racial variation in the prevalence of atrial fibrillation among patients with heart failure. J Am Coll Cardiol 2004; 43: 429-435.
18. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A, et al. Prevention of Atrial Fibrillation: Report from a National Heart, Lung, and Blood Institute Workshop. Circulation 2009; 119: 606-618.
19. Lubitz SA, Ozcan C, Magnani JW, Kääb S, Benjamin EJ, Ellinor PT. Genetics of atrial fibrillation: Implications for future research directions and personalized medicine. Circ Arrhythm Electrophysiol 2010; 3: 291-299.
20. Tsai CT, Lai LP, Hwang JJ, Lin JL, Chiang FT. Molecular genetics of atrial fibrillation. J Am Coll Cardiol 2008; 52: 241-250.
21. Roberts JD, Gollob MH. Impact of genetic discoveries on the classification of lone atrial fibrillation. J Am Coll Cardiol 2010; 55: 705-712.
22. Kozlowski D, Budrejko S, Lip GY, Rysz J, Mikhailidis DP, Raczak G, et al. Lone atrial fibrillation: What do we know? Heart 2010; 96: 498-503.
23. Tuteja D, Rafizadeh S, Timofeyev V, Wang S, Zheng Z, Li N, et al. Cardiac small conductance Ca2+-activated K+ channel subunits form heteromultimers via the coiled-coil domains in the C termini of the channels. Circ Res 2010; 107: 851-859.
24. Tuteja D, Xu D, Timofeyev V, Lu L, Sharma D, Zhang Z, et al. Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes. Am J Physiol Heart Circ Physiol 2005; 289: H2714-H2723.
25. Ozgen N, Dun W, Sosunov EA, Anyukhovsky EP, Hirose M, Duffy HS, et al. Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites. Cardiovasc Res 2007; 4: 758-769.
26. Li N, Timofeyev V, Tuteja D, Xu D, Lu L, Zhang Q, et al. Ablation of a Ca2+-activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation. J Physiol 2009; 587: 1087-1100.
27. Diness JG, Sorensen US, Nissen JD, Al-Shahib B, Jespersen T, Grunnet M, et al. Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 380-390.
28. Takeuchi F, Kashida M, Okazaki O, Tanaka Y, Fukuda S, Kshima T, et al. Evaluation of pharmacogenetic algorithm for warfarin dose requirements in Japanese patients. Circ J 2010; 74: 977-982.
29. Inoue H. Antithrombotic therapy. Circ J 2010; 74: 2542-2545.